Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2015
Volume 2015 eBook
Issue 2

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

 

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

Download

Pharmaceutical Technology’s 2015 Bioprocessing and Sterile Manufacturing eBook


 

Articles in this issue
PTeBook0515_024-030_Container200.jpg
Sterilization Effects on Elastomers in Sterile Parenteral Drug Products
PTebook0515_Linde200.jpg
Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study
PTeBook0515_EMDConfarma200.jpg
Validating and Implementing a Rapid Sterility Testing Method
PTeBook0515_Vetter200.jpg
Disposable Technology versus Traditional Stainless Steel--When Time Means Money
PTeBook0515_Cleanroom200.jpg
Cleanroom and Facility Planning: Getting Beyond Cost Per Square Foot
PTeBook0515_Aging_Facilities200.jpg
Aging Facilities: Aseptic Manufacturing Faces the Future
Recent Videos
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Related Content
DCAT Week 2025: Sustainability in Medical Propellants

DCAT Week 2025: Sustainability in Medical Propellants

Patrick Lavery
March 24th 2025
Article

PharmTech Group chatted with Markus Laubscher of Orbia during DCAT Week 2025, covering the topics of sustainability, regulatory hurdles, next-generation innovation, and the DCAT Week experience.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

SGD Pharma Details Latest Sustainability Investments at DCAT Week 2025

Patrick Lavery
March 19th 2025
Article

The company is highlighting its commitment to next-generation glass manufacturing in efforts to strengthen the pharmaceutical supply chain.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

DCAT Member Companies Present Latest News to Start DCAT Week 2025

Patrick Lavery
March 17th 2025
Article

The Member Company Announcement Forum is the kickoff event of the annual DCAT Week in New York City, which is being held from March 17–20.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

CordenPharma and Viking Therapeutics to Partner for Integrated Supply of GLP-1s

Patrick Lavery
March 13th 2025
Article

The multi-year strategic partnership is intended to support commercial demand of Viking Therapeutics’ GLP-1 candidate, VK2735.